This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignees: Beijing Wisdomab Biotechnology Co., Ltd., Chongqing Genrix Biopharmaceutical Co., Ltd., Genrix (Shanghai) Biopharmaceutical Co. Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 4 
3 out of 5 
2 out of 5 Years Active: 2026
Title: Innovations by Inventor Xiaowei Zhou
Introduction
Xiaowei Zhou is an inventor based in Beijing, CN. He is known for his contributions to the field of biotechnology, particularly in the development of antibodies for medical applications. Although he currently holds no granted patents, his work is significant in advancing therapeutic options.
Latest Patent Applications
Xiaowei Zhou has submitted several notable patent applications. One of his latest applications is for an "ANTIBODY FOR TETANUS TOXIN AND USE THEREOF." This application describes a bispecific antibody and a monoclonal antibody designed to neutralize the tetanus toxin. The bispecific antibody features two antigen-binding fragments that target different epitopes of the toxin, enhancing its neutralizing activity. Additionally, he has applied for "ANTIBODIES AGAINST HUMAN TSLP AND USE THEREOF," which includes a bispecific antibody and a monoclonal antibody against human thymic stromal lymphopoietin (TSLP), along with their potential uses.
Conclusion
Xiaowei Zhou's innovative work in antibody development showcases his commitment to advancing medical science. His latest patent applications reflect his focus on creating effective therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile